We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




"Father of Stem Cell Research” Wins Nobel Prize

By Biotechdaily staff writers
Posted on 22 Oct 2007
Sir Martin Evans has been awarded the Nobel Prize in physiology or medicine for 2007, alongside Professor Mario R. More...
Capecchi and Professor Oliver Smithies, for their discoveries of the principles for introducing specific gene modifications in mice by the use of embryonic stem cells.

Widely acclaimed as the father of stem cell research in the United Kingdom (UK), Sir Martin won the Nobel Prize for his work in gene targeting, a technique used to inactivate single genes. With gene targeting it is now possible to produce almost any type of DNA modification in the mouse genome, allowing scientists to establish the roles of individual genes in health and disease. Gene targeting has already produced more than five hundred different mouse models of human disorders, including cardiovascular and neuro-degenerative diseases, diabetes, and cancer. These gene experiments have elucidated the roles of numerous genes in embryonic development, adult physiology, ageing, and disease. To date, more than ten thousand mouse genes (approximately half of the genes in the mammalian genome) have been "knocked out”.

The cell types initially studied by Capecchi and Smithies could not be used to create gene-targeted animals. Sir Martin Evans discovered that chromosomally normal cell cultures could be established directly from early mouse embryos. These cells are now referred to as embryonic stem (ES) cells. He then developed ways to culture ES cells derived from the mouse blastocyst--the ball of cells formed after fertilization. The technique paved the way for targeted genetic manipulation and experimental mammalian genetics; tools used everyday by scientists in their efforts to understand the influence genes have on disease development.

The winners of the Nobel Prize in physiology or medicine for 2007 are:

Sir Martin J. Evans, Ph.D., former director of the school of biosciences and professor of mammalian genetics at Cardiff University (UK). Sir Martin Evans was knighted for services to medical science in 2004.

Professor Mario R. Capecchi, Ph.D., professor of human genetics and biology at the University of Utah (Salt Lake City, UT, USA).

Professor Oliver Smithies, Ph.D., professor of pathology and laboratory medicine at the University of North Carolina (Chapel Hill, USA).


Related Links:
Cardiff University
University of Utah
University of North Carolina

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.